![FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death](https://cardiovascularbusiness.com/sites/default/files/2022-08/image-1.jpg)
FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death
Medtronic India - The Cardiac Resynchronisation Therapy is a clinically proven treatment for certain patients with heart failure. It improves the heart's ability to pump blood and oxygen to the body with
![Medtronic Receives CE Mark for its Next Generation Cardiac Resynchronization Therapy-Pacemakers - Medical Design and Outsourcing Medtronic Receives CE Mark for its Next Generation Cardiac Resynchronization Therapy-Pacemakers - Medical Design and Outsourcing](https://media-ecn.s3.amazonaws.com/embedded_image/2017/02/170224-medtronic%20pacemakers.png)